These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 9567352

  • 1. [New spine and non-spine fractures in 871 women/year treated with oral pamidronate plus calcium and vitamin D supplements].
    Man Z, Otero AB.
    Medicina (B Aires); 1997; 57 Suppl 1():32-6. PubMed ID: 9567352
    [Abstract] [Full Text] [Related]

  • 2. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA, Dussault PM, Thakore-James M, Gagnon D, Baker E, Davis SA, Houranieh AM.
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [Abstract] [Full Text] [Related]

  • 3. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
    Chesnut CH, Skag A, Christiansen C, Recker R, Stakkestad JA, Hoiseth A, Felsenberg D, Huss H, Gilbride J, Schimmer RC, Delmas PD, Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE).
    J Bone Miner Res; 2004 Aug; 19(8):1241-9. PubMed ID: 15231010
    [Abstract] [Full Text] [Related]

  • 4. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
    Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW, Dequeker J, Favus M.
    N Engl J Med; 1995 Nov 30; 333(22):1437-43. PubMed ID: 7477143
    [Abstract] [Full Text] [Related]

  • 5. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
    Dodidou P, Bruckner T, Hosch S, Haass M, Klar E, Sauer P, Ziegler R, Leidig-Bruckner G.
    Osteoporos Int; 2003 Jan 30; 14(1):82-9. PubMed ID: 12577189
    [Abstract] [Full Text] [Related]

  • 6. Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women.
    Bruyere O, Varela AR, Adami S, Detilleux J, Rabenda V, Hiligsmann M, Reginster JY.
    Eur J Epidemiol; 2009 Jan 30; 24(11):707-12. PubMed ID: 19728118
    [Abstract] [Full Text] [Related]

  • 7. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP.
    Arch Intern Med; 2003 Oct 13; 163(18):2237-46. PubMed ID: 14557222
    [Abstract] [Full Text] [Related]

  • 8. Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study.
    Matsumoto T, Hagino H, Shiraki M, Fukunaga M, Nakano T, Takaoka K, Morii H, Ohashi Y, Nakamura T.
    Osteoporos Int; 2009 Aug 13; 20(8):1429-37. PubMed ID: 19101754
    [Abstract] [Full Text] [Related]

  • 9. Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial).
    Ringe JD, Farahmand P, Schacht E, Rozehnal A.
    Rheumatol Int; 2007 Mar 13; 27(5):425-34. PubMed ID: 17216477
    [Abstract] [Full Text] [Related]

  • 10. Zoledronic acid increases bone mineral density and improves health-related quality of life over two years of treatment in Chinese women with postmenopausal osteoporosis.
    Huang S, Lin H, Zhu X, Chen X, Fan L, Liu C.
    Endokrynol Pol; 2014 Mar 13; 65(2):96-104. PubMed ID: 24802732
    [Abstract] [Full Text] [Related]

  • 11. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
    Meunier PJ, Sebert JL, Reginster JY, Briancon D, Appelboom T, Netter P, Loeb G, Rouillon A, Barry S, Evreux JC, Avouac B, Marchandise X.
    Osteoporos Int; 1998 Mar 13; 8(1):4-12. PubMed ID: 9692071
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Extended use, up to 6 years, of an oral amino-bisphosphonate in patients with established osteoporosis].
    Zanchetta JR, Spivacow RF, Bogado C, Sarli M, Plotkin H, Roldán EJ.
    Medicina (B Aires); 1997 Mar 13; 57 Suppl 1():37-44. PubMed ID: 9567353
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial.
    Reginster JY, Meurmans L, Zegels B, Rovati LC, Minne HW, Giacovelli G, Taquet AN, Setnikar I, Collette J, Gosset C.
    Ann Intern Med; 1998 Jul 01; 129(1):1-8. PubMed ID: 9652994
    [Abstract] [Full Text] [Related]

  • 17. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis.
    Makras P, Hamdy NA, Zwinderman AH, Ballieux BE, Papapoulos SE.
    Bone; 2009 May 01; 44(5):766-71. PubMed ID: 19442613
    [Abstract] [Full Text] [Related]

  • 18. Increases in hip and spine bone mineral density are predictive for vertebral antifracture efficacy with ibandronate.
    Miller PD, Delmas PD, Huss H, Patel KM, Schimmer RC, Adami S, Recker RR.
    Calcif Tissue Int; 2010 Oct 01; 87(4):305-13. PubMed ID: 20737140
    [Abstract] [Full Text] [Related]

  • 19. Ten-year fracture risk in the assessment of osteoporosis management efficacy in postmenopausal women: a pilot study.
    Pluskiewicz W, Drozdzowska B, Adamczyk P.
    Climacteric; 2013 Feb 01; 16(1):117-26. PubMed ID: 22335356
    [Abstract] [Full Text] [Related]

  • 20. Treatment of the vertebral crush fracture syndrome with enteric-coated sodium fluoride tablets and calcium supplements.
    Nagant de Deuxchaisnes C, Devogelaer JP, Depresseux G, Malghem J, Maldague B.
    J Bone Miner Res; 1990 Mar 01; 5 Suppl 1():S5-26. PubMed ID: 2187327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.